Global Biosurgery Market (2020 to 2025) - Growth, Trends, and Forecast (2020 - 2025) -

DUBLIN--()--The "Biosurgery Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to's offering.

The biosurgery market studied was anticipated to grow with a CAGR of 7.4%, during the forecast period.

The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products.

The global increase in the number of geriatrics population and obese people is likely to lead to numerous health consequences, like greater incidences of ortho and neuro problems. Consequently, the geriatric population and population with obesity are at a higher risk of multiple disorders and diseases.

According to the United Nations report in 2017, there were an estimated 962 million people aged 60 or over in the world, comprising 13% of the global population. The population aged 60 or above is growing at a rate of about 3% per year. It was estimated that Europe had the highest percentage of the population aged 60 or over in 2017. Thus, the rise in the geriatric and obese population is acting as a major driver for the growth of the biosurgery market.

The biosurgery market is moderately competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format.
  • Report customization as per the client's requirements.
  • 3 months of analyst support.

Key Market Trends

Neurology Segment is Expected to Grow with Good CAGR in the Application Segment

  • Neurology and spine-related surgery applications of biosurgery are the major market segments and their growth is driven by a mainly wide application of bone graft substitute products in different biosurgery processes.
  • Another major application segment of biosurgery is orthopedic surgery. Due to the fact that each year the number of orthopedic cases is increasing primarily due to factors such as the increasing obese and aging population.
  • Even the cardiovascular surgery segment is expected to grow with a positive CAGR in the forecast period, and factors such as the increasing number of cardiac problems in the people across the globe are augmenting the market growth.
  • For instance, according to the data provided by the American Heart Association 2019, Cardiovascular disease (CVD) was listed as the underlying cause of death, which have accounted for approximately 840,678 deaths in the United States in the year 2016, this is approximately 1 of every 3 deaths in the region.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. This is due to the increasing number of surgeries, rising obese patients and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors such as increasing count of geriatrics, along with the growing healthcare industry, which is anticipated to stimulate the demand in this region. Substantial investments by governments to strengthen public healthcare delivery is a key factor augmenting the growth of the market.

Key Topics Covered:


1.1 Study Deliverables

1.2 Study Assumptions

1.3 Scope of the Study




4.1 Market Overview

4.2 Market Drivers

4.3 Market Restraints

4.4 Porter's Five Force Analysis


5.1 By Product

5.1.1 Bone-Graft Substitutes

5.1.2 Soft-Tissue Attachments

5.1.3 Hemostatic Agents

5.1.4 Surgical Sealants and Adhesives

5.1.5 Adhesion Barriers

5.1.6 Others

5.2 By Application

5.2.1 Orthopedic Surgery

5.2.2 General Surgery

5.2.3 Neurological Surgery

5.2.4 Cardiovascular Surgery

5.2.5 Gynecological Surgery

5.2.6 Others

5.3 Geography

5.3.1 North America United States Canada Mexico

5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe

5.3.3 Asia Pacific

5.3.4 Middle East and Africa

5.3.5 South America


6.1 Company Profiles

6.1.1 Baxter International, Inc.

6.1.2 B.Braun Melsungen AG

6.1.3 Becton, Dickinson and Company (C.R. Bard)

6.1.4 Johnson & Johnson

6.1.5 Medtronic, PLC.

6.1.6 MAQUET Holding B.V. & Co. Kg. (Getinge Group)

6.1.7 Cohera Medical Inc.

6.1.8 Integra Lifesciences Holdings Corporation

6.1.9 Commonwealth Serum Laboratories (CSL)

6.1.10 Hemostasis, LLC

6.1.11 CryoLife, Inc.


For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900